Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

Item

http://www.wikidata.org/entity/Q26825271

Q26825271

about

Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease Understanding and Managing Pregnancy in Patients with Lupus The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia Angiogenic factors in preeclampsia: potential for diagnosis and treatment Managing lupus patients during pregnancy Angiogenic factors in diagnosis, management, and research in preeclampsia.A Dormant Microbial Component in the Development of Preeclampsia Enhancement of the HIF-1α/15-LO/15-HETE axis promotes hypoxia-induced endothelial proliferation in preeclamptic pregnancy.Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension Relationship between maternal immunological response during pregnancy and onset of preeclampsia.A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review.sFLT1 in preeclampsia: trophoblast defense against a decidual VEGFA barrage?Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker.Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia.Role of the angiopoietin/Tie system in pregnancy (Review).Risk factors and effective management of preeclampsia Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies.Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments.Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry.Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia.Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia.Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis.Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.Management of pregnancy in systemic lupus erythematosus.Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease.Clinical applications of biomarkers in preeclampsia.Pre-eclampsia part 2: prediction, prevention and management.Fetal DNA in maternal plasma in preeclamptic pregnancies.Angiogenic biomarkers in pregnancy: defining maternal and fetal health.Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.

P2860

Q26747071-F1BD2613-A63A-4A0A-8FE0-CC34E91DE19D Q26798179-2E0722B0-B811-40B0-91E6-9DECE9DC9331 Q26798193-01A82E6F-B37D-46A0-95E7-38C64DF4FFA7 Q26825774-A67B87EA-B3D5-4F40-B556-334C544FD8DB Q27002228-A6C9FD78-3365-4E75-9281-772B9446308D Q27692060-D9E585C6-AC26-46AA-B73D-BDE0FB807EB8 Q28069689-57BD259B-3ABE-44A3-9298-ECEBDCDECAD1 Q33568126-D1826409-309A-4A12-814F-47150666806B Q33579089-5769474A-F6FF-47D0-A0FC-2B41DCAABBDD Q33724115-3FB80666-DB67-4E1F-9BF6-15635FB22D16 Q33765975-960CEEE0-BFE6-4B79-85BB-E7521B3238B0 Q33844319-8ABA623A-8F0C-48E2-8A1E-CA09A892E3E7 Q33863973-80102B2C-5CF5-4412-A6CD-947F5AE0B8CB Q34173305-8D805C44-8D50-46B1-A22D-F56D85D2A502 Q34245668-2D529A0C-E0EF-4AAC-90B8-6F2C409D7A5D Q34461130-23D72E6D-891C-4B41-891F-8E252527F56A Q34548799-21685DA5-DCE4-4688-B6D1-68333A9C5EA2 Q35062407-E84C9650-15DA-40F3-AB84-FDDEC7D50595 Q35070413-74F426E5-7432-4921-981D-FEFDFAF727A9 Q35094987-B467707D-5037-43EB-9CB3-2EAA5B5392DC Q35159581-559A8D09-02EE-4DBF-9ECE-A58087A578D1 Q35162151-FB0329FA-6C30-4D54-91B9-EF1BA1013FB4 Q35567911-4C14AC21-75A8-4C3F-B96A-0C5C649050DC Q35655056-DAE669BF-1E69-4C9E-B887-51C00EA07ACA Q36200068-AAC2B69B-AF3E-461E-834E-C29451B893C3 Q36407107-05320BCB-174A-4EAE-A55E-8C1AB0B9B288 Q36731791-913A7853-2B56-4CBC-939D-FD8FE384EB9D Q36826519-F5E2849B-8634-4DE0-A0AB-80B4D6506E7F Q37097779-EEC73F0E-D77E-430F-8A44-FA4EB20898DE Q37187628-9F57BAEE-BA53-4F0F-9AA3-527FB1D8E720 Q37229446-FF90F315-9B07-4006-A4B6-D66D63213E8F Q37348561-FFE02056-41A6-4CC5-9FF0-EFF63DC05AB6 Q38036105-8647EA7C-4F44-4C10-9064-9CAC99B7E3A6 Q38207099-27079100-BCD9-4610-9143-E8B6AC576DB6 Q38209381-8B3B1592-02B4-4D5E-885F-F0A4415AA653 Q38227251-0A9AFD02-9BF5-487B-A246-42FF2FD4E39E Q38257762-2B7168E3-C74F-4C70-BF03-345AC405EC5B Q38370968-2C17B2AF-3AB6-4ED8-9F48-8C336915D979 Q38458497-4161AEDE-6D4D-4B1A-909A-B59DF536E72E Q38594110-9E58B90E-5408-489A-9416-8718D9353785

P2860

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

Item

http://www.wikidata.org/entity/Q26825271

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu